Changes in the prevalence of COPD in Korea between 2001 and 2011 in the KNHANES data

Respiratory Medicine

Volumn 125, Issue , 2017, Pages 12-18

  Hong, Ji Young ^b,c   Jung, Ji Ye ^a   Lee, Myung Goo ^b,c   Kim, Se Kyu ^a   Chang, Joon ^a   Lee, Chang Youl ^b,c   Kim, Young Sam ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Hallym University College of Medicine   (South Korea)

Author keywords

Chronic obstructive lung disease; Prevalence; Smoking

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; SMOKING; SPIROMETER; SPIROMETRY; COST OF ILLNESS; ECONOMICS; LUNG; LUNG FUNCTION TEST; NUTRITION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SOCIOECONOMICS; SOUTH KOREA; VITAL CAPACITY;

ADULT; AGED; COST OF ILLNESS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SOCIOECONOMIC FACTORS; VITAL CAPACITY;

EID: 85014092237     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2017.02.019     Document Type: Article

References (29)

1. [1] Halpin, D.M., Miravitlles, M., Chronic obstructive pulmonary disease: the disease and its burden to society. Proc. Am. Thorac. Soc. 3:7 (2006), 619–623.
2. [2] Murray, C.J., Lopez, A.D., Measuring the global burden of disease. N. Engl. J. Med. 369:5 (2013), 448–457.
3. [3] WHO, Global Status Report on Noncommunicable Diseases 2010., 2011.
4. [4] Vanfleteren, L.E., Franssen, F.M., Wesseling, G., Wouters, E.F., The prevalence of chronic obstructive pulmonary disease in Maastricht, The Netherlands. Respir. Med. 106:6 (2012), 871–874.
5. [5] Adeloye, D., Basquill, C., Papana, A., Chan, K.Y., Rudan, I., Campbell, H., An estimate of the prevalence of COPD in Africa: a systematic analysis. COPD 12:1 (2015), 71–81.
6. [6] Doney, B., Hnizdo, E., Dillon, C.F., Paulose-Ram, R., Tilert, T., Wolz, M., Beeckman-Wagner, L.A., Prevalence of airflow obstruction in U.S. Adults aged 40-79 Years: NHANES data 1988-1994 and 2007-2010. COPD 12:4 (2015), 355–365.
7. [7] Yoo, K.H., Kim, Y.S., Sheen, S.S., Park, J.H., Hwang, Y.I., Kim, S.H., Yoon, H.I., Lim, S.C., Park, J.Y., Park, S.J., Seo, K.H., Kim, K.U., Oh, Y.M., Lee, N.Y., Kim, J.S., Oh, K.W., Kim, Y.T., Park, I.W., Lee, S.D., Kim, S.K., Kim, Y.K., Han, S.K., Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean national health and nutrition examination survey, 2008. Respirology 16:4 (2011), 659–665.
8. [8] Kim, C., Yoo, K.H., Rhee, C.K., Yoon, H.K., Kim, Y.S., Lee, S.W., Oh, Y.M., Lee, S.D., Lee, J.H., Kim, K.J., Kim, J.H., Park, Y.B., Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea. Int. J. Tuberc. Lung Dis. 18:6 (2014), 737–743.
9. [9] Chung, K., Kim, K., Jung, J., Oh, K., Oh, Y., Kim, S., Kim, J., Kim, Y., Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea. BMC Pulm. Med., 14, 2014, 27.
10. [10] Donner, C.F., Virchow, J.C., Lusuardi, M., Pharmacoeconomics in COPD and inappropriateness of diagnostics, management and treatment. Respir. Med. 105:6 (2011), 828–837.
11. [11] Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C.P., Gustafsson, P., Jensen, R., Johnson, D.C., MacIntyre, N., McKay, R., Navajas, D., Pedersen, O.F., Pellegrino, R., Viegi, G., Wanger, J., Force, A.E.T., Standardisation of spirometry. Eur. Respir. J. 26:2 (2005), 319–338.
12. [12] Choi, J.K., Paek, D., Lee, J.O., Normal predictive values of spirometry in Korean population. Tuberc. Respir. Dis. 58:3 (2005), 230–242.
13. [13] Halldin, C.N., Doney, B.C., Hnizdo, E., Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors. Chron. Respir. Dis. 12:1 (2015), 47–60.
14. [14] Klein, R.J., Schoenborn, C.A., Age Adjustment Using the 2000 Projected U.S. Population. Healthy People Statistical Notes, No 20. 2001, National center for Health Statistics, Hyattsville, Maryland.
15. [15] Park, H., Jung, S.Y., Lee, K., Bae, W.K., Lee, K., Han, J.S., Kim, S., Choo, S., Jeong, J.M., Kim, H.R., Ro, H.J., Jeong, H., Prevalence of chronic obstructive lung disease in Korea using data from the fifth Korea national health and nutrition examination survey. Korean J. Fam. Med. 36:3 (2015), 128–134.
16. [16] Ford, E.S., Croft, J.B., Mannino, D.M., Wheaton, A.G., Zhang, X., Giles, W.H., COPD surveillance–United States, 1999-2011. Chest 144:1 (2013), 284–305.
17. [17] Backman, H., Eriksson, B., Ronmark, E., Hedman, L., Stridsman, C., Jansson, S.A., Lindberg, A., Lundback, B., Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir. Med. 114 (2016), 103–110.
18. [18] Soriano, J.B., Ancochea, J., Miravitlles, M., Garcia-Rio, F., Duran-Tauleria, E., Munoz, L., Jimenez-Ruiz, C.A., Masa, J.F., Viejo, J.L., Villasante, C., Fernandez-Fau, L., Sanchez, G., Sobradillo-Pena, V., Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur. Respir. J. 36:4 (2010), 758–765.
19. [19] Vasankari, T.M., Impivaara, O., Heliovaara, M., Heistaro, S., Liippo, K., Puukka, P., Saarelainen, S., Kanervisto, M., Jousilahti, P., No increase in the prevalence of COPD in two decades. Eur. Respir. J. 36:4 (2010), 766–773.
20. [20] Gershon, A., Hwee, J., Victor, J.C., Wilton, A., Wu, R., Day, A., To, T., Mortality trends in women and men with COPD in Ontario, Canada, 1996-2012. Thorax 70:2 (2015), 121–126.
21. [21] Sorheim, I.C., Johannessen, A., Gulsvik, A., Bakke, P.S., Silverman, E.K., DeMeo, D.L., Gender differences in COPD: are women more susceptible to smoking effects than men?. Thorax 65:6 (2010), 480–485.
22. [22] Prescott, E., Bjerg, A.M., Andersen, P.K., Lange, P., Vestbo, J., Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur. Respir. J. 10:4 (1997), 822–827.
23. [23] Lopez-Campos, J.L., Ruiz-Ramos, M., Soriano, J.B., Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. Lancet Respir. Med. 2:1 (2014), 54–62.
24. [24] Lopez Varela, M.V., Montes de Oca, M., Halbert, R.J., Muino, A., Perez-Padilla, R., Talamo, C., Jardim, J.R., Valdivia, G., Pertuze, J., Moreno, D., Menezes, A.M., Team, P., Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur. Respir. J. 36:5 (2010), 1034–1041.
25. [25] Kim, J., Rhee, C.K., Yoo, K.H., Kim, Y.S., Lee, S.W., Park, Y.B., Lee, J.H., Oh, Y., Lee, S.D., Kim, Y., Kim, K., Yoon, H., The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data. Int. J. Chron. Obstruct Pulmon Dis. 8 (2013), 561–568.
26. [26] Khakban, A., Sin, D.D., FitzGerald, J.M., Ng, R., Zafari, Z., McManus, B., Hollander, Z., Marra, C.A., Sadatsafavi, M., Ten-year trends in direct costs of COPD: a population-based study. Chest 148:3 (2015), 640–646.
27. [27] Jensen, M.B., Fenger-Gron, M., Fonager, K., Omland, O., Vinding, A.L., Hansen, J.G., Chronic obstructive pulmonary disease involves substantial health-care service and social benefit costs. Dan. Med. J., 60(1), 2013, A4557.
28. [28] Jansson, S.A., Andersson, F., Borg, S., Ericsson, A., Jonsson, E., Lundback, B., Costs of COPD in Sweden according to disease severity. Chest 122:6 (2002), 1994–2002.
29. [29] Masa, J.F., Sobradillo, V., Villasante, C., Jimenez-Ruiz, C.A., Fernandez-Fau, L., Viejo, J.L., Miravitlles, M., [Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study]. Arch. Bronconeumol 40:2 (2004), 72–79.